This study is looking at how a text messaging program called "Dulce Digital" combined with a continuous glucose monitor (CGM) like the Dexcom G7 can help people with Type 2 Diabetes manage their health. You would receive daily text messages about diabetes care and use a CGM device for six months to track your blood sugar levels in real-time. The main goal is to see if this combination helps improve your HbA1c (a measure of average blood sugar over 2-3 months) after six months. You might be able to join if you have Type 2 Diabetes, are not using insulin, have an A1c between 7.5% and 12.0%, and can speak English, Spanish, or Arabic. The study plans to enroll 140 participants, but its current recruitment status is unclear.

Study design

This study is an interventional study, meaning participants will receive specific treatments. It aims to enroll 140 participants.

What's involved

You would receive 2-3 text messages daily for the first three months, then fewer messages for the next three months. You would also use a new CGM device every 10 days for six months.

Compensation

Not stated in the trial record.

Follow-up

Your HbA1c will be measured at 6 months to assess the study's effectiveness.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.